COMPOSITIONS AND METHODS FOR REGENERATION OF BONE TISSUE
Embodiments of the disclosure relate to compositions that stimulate the generation or regeneration of bone tissue, increasing the rate of bone healing or repair inducing the formation of osteoblasts, inducing the differentiation of mesenchymal stem cells, and the treatment of a disease or disorder in a subject.
1 . A method of generating or regenerating bone tissue, the method comprising:
a) preparing a composition comprising a multivalent metal salt and an osteoinductive factor in an aqueous solution or suspension;
b) applying the composition to a site (e.g., into or onto bone, or in between bones); and
c) allowing the composition to harden, cure, or be resorbed by bone;
wherein the osteoinductive factor is a compound of Formula (I):
or a pharmaceutically acceptable salt thereof, wherein:
L is O, S, NH, or CH 2 ;
each of R 1a and R 1b is independently H, optionally substituted alkyl, or optionally substituted aryl;
R 2 is H, NR 4a R 4b , C(O)R 5 , or C(O)OR 5 ;
R 3 is H, optionally substituted alkyl, or optionally substituted aryl;
each of R 4a and R 4a is independently H, C(O)R 6 , or optionally substituted alkyl;
R 5 is H, optionally substituted alkyl, or optionally substituted aryl;
R 6 is optionally substituted alkyl or optionally substituted aryl; and
each of x and y is independently 0, 1, 2, or 3; and
the multivalent metal salt comprises calcium.
2 . The method of claim 1 , wherein the generation or regeneration is derived from the increased action of osteoblast cells.
3 . The method of claim 1 , wherein the generation or regeneration further comprises an increase in alkaline phosphatase activity, e.g., relative to a reference standard.
4 . A method of inducing osteoblast formation, the method comprising:
a) preparing a composition comprising a multivalent metal salt and an osteoinductive factor in an aqueous solution or suspension;
b) applying the composition to a site (e.g., into or onto bone, or in between bones); and
c) allowing the composition to harden, cure, or be resorbed by bone;
wherein the osteoinductive factor is a compound of Formula (I):
or a pharmaceutically acceptable salt thereof, wherein:
L is O, S, NH, or CH 2 ;
each of R 1a and R 1b is independently H, optionally substituted alkyl, or optionally substituted aryl;
R 2 is H, NR 4a R 4b , C(O)R 5 , or C(O)OR 5 ;
R 3 is H, optionally substituted alkyl, or optionally substituted aryl;
each of R 4a and R 4a is independently H, C(O)R 6 , or optionally substituted alkyl;
R 5 is H, optionally substituted alkyl, or optionally substituted aryl;
R 6 is optionally substituted alkyl or optionally substituted aryl; and
each of x and y is independently 0, 1, 2, or 3; and
the multivalent metal salt comprises calcium.
5 . The method of claim 4 , wherein the formation of osteoblasts is derived from the differentiation of mesenchymal stem cells.
6 . A method of treating or preventing a bone disease or disorder in a subject, the method comprising:
a) preparing a composition comprising a multivalent metal salt and an osteoinductive factor in an aqueous solution or suspension;
b) applying the composition to a site (e.g., into or onto bone, or in between bones); and
c) allowing the composition to harden, cure, or be resorbed by bone;
wherein the osteoinductive factor is a compound of Formula (I):
or a pharmaceutically acceptable salt thereof, wherein:
L is O, S, NH, or CH 2 ;
each of R 1a and R 1b is independently H, optionally substituted alkyl, or optionally substituted aryl;
R 2 is H, NR 4a R 4b , C(O)R 5 , or C(O)OR 5 ;
R 3 is H, optionally substituted alkyl, or optionally substituted aryl;
each of R 4a and R 4a is independently H, C(O)R 6 , or optionally substituted alkyl;
R 5 is H, optionally substituted alkyl, or optionally substituted aryl;
R 6 is optionally substituted alkyl or optionally substituted aryl; and
each of x and y is independently 0, 1, 2, or 3; and
the multivalent metal salt comprises calcium.
7 . The method of claim 6 , wherein the bone disease or disorder comprises cancer (e.g., osteosarcoma), osteoporosis, rickets, osteogenesis imperfecta, Paget's disease of the bone, hearing loss, renal osteodystrophy, a malignancy of the bone, infection of the bone, osteonecrosis, or other genetic or developmental disease.
8 . The method of claim 1 , wherein the multivalent metal salt comprises tetracalcium phosphate.
9 . The method of claim 1 , wherein the composition comprises tetracalcium phosphate and at least one other multivalent calcium compound.
10 - 16 . (canceled)
17 . The method of claim 1 , wherein the compound of Formula (I) is phosphoserine.
18 . The method of claim 1 , wherein the osteoinductive factor (e.g., a compound of Formula (I)) is present in an amount greater than or equal to about 10% (w/w) of the total composition.
19 . The method of claim 1 , wherein the aqueous solution or suspension comprises water, saliva, saline, serum, plasma, or blood.
20 . The method of claim 1 , wherein the multivalent metal salt is initially provided as granules or a powder.
21 . The method of claim 1 , the composition further comprises an additive.
22 . The method of claim 1 , wherein the method further comprises release of the osteoinductive factor from the composition.
23 . The method of claim 22 , wherein the release of the osteoinductive factor takes place over the course of minutes, hours, days, months, or years.
24 . The method of claim 1 , wherein the generation or regeneration of bone tissue or the formation of osteoblasts is correlated with an increase in the levels of a biomarker relative to a reference standard.
25 . The method of claim 24 , where the biomarker comprises alkaline phosphatase, osteocalcin, matrix gla protein, or osteopontin, or collagen (e.g., type I collagen).
26 . A kit for use in the generation or regeneration of bone tissue, wherein the kit comprises:
(a) an osteoinductive factor comprising a compound of Formula (I):
or a pharmaceutically acceptable salt thereof, wherein:
L is O, S, NH, or CH 2 ;
each of R 1a and R 1b is independently H, optionally substituted alkyl, or optionally substituted aryl;
R 2 is H, NR 4a R 4b , C(O)R 5 , or C(O)OR 5 ;
R 3 is H, optionally substituted alkyl, or optionally substituted aryl;
each of R 4a and R 4a is independently H, C(O)R 6 , or optionally substituted alkyl;
R 5 is H, optionally substituted alkyl, or optionally substituted aryl;
R 6 is optionally substituted alkyl or optionally substituted aryl; and
each of x and y is independently 0, 1, 2, or 3;
(b) a multivalent metal salt comprising calcium;
(c) an aqueous medium; and optionally,
(d) an additive (e.g., biologically active substance),
wherein each of (a), (b), (c), and (d) is contained within a separate container.
27 . The method of claim 4 , wherein the compound of Formula (I) is phosphoserine.
28 . The method of claim 6 , wherein the compound of Formula (I) is phosphoserine.
29 . The method of claim 4 , wherein the osteoinductive factor (e.g., a compound of Formula (I)) is present in an amount greater than or equal to about 10% (w/w) of the total composition.
30 . The method of claim 6 , wherein the osteoinductive factor (e.g., a compound of Formula (I)) is present in an amount greater than or equal to about 10% (w/w) of the total composition.
31 . The method of claim 4 , the composition further comprises an additive.
32 . The method of claim 6 , the composition further comprises an additive.
33 . The method of claim 4 , wherein the method further comprises release of the osteoinductive factor from the composition.
34 . The method of claim 33 , wherein the release of the osteoinductive factor takes place over the course of minutes, hours, days, months, or years.
35 . The method of claim 6 , wherein the method further comprises release of the osteoinductive factor from the composition.
36 . The method of claim 35 , wherein the release of the osteoinductive factor takes place over the course of minutes, hours, days, months, or years.